• SU6656 Src Tyrosine Kinases Inhibitor: Protocols for Platele

  2026-05-13

  Leverage SU6656 Src tyrosine kinases inhibitor to boost hiPSC-derived platelet yield and sensitize tumor vasculature to radiotherapy. This guide decodes experimental workflows, protocol tweaks, and key troubleshooting strategies for maximizing both megakaryocyte polyploidization and antiangiogenic effects.

• CLK2 Inhibition to Overcome Platinum Resistance in Ovarian C

  2026-05-13

  This study uncovers the mechanistic role of Cdc2-like kinase 2 (CLK2) in mediating platinum resistance in ovarian cancer by enhancing DNA repair via BRCA1 phosphorylation. The findings suggest that targeting CLK2 may provide a new strategy for overcoming chemoresistance, with translational implications for splicing modulation research and therapeutic development.

• Precision Native PAGE: Advancing Protein Characterization wi

  2026-05-12

  Explore how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit enables high-resolution, native protein gel electrophoresis while preserving protein structure and activity. This article offers a unique, evidence-driven perspective on optimizing acidic protein analysis and experimental workflows.

• Cinoxacin: Quinolone Antibiotic Workflows for Gram-Negative

  2026-05-12

  Cinoxacin, a robust quinolone antibiotic, empowers researchers with reproducible inhibition profiles for gram-negative pathogen studies. This article details advanced experimental workflows, protocol optimizations, and troubleshooting strategies for urinary tract infection and antibiotic resistance research, grounded in benchmark peer-reviewed evidence.

• Amyloid β-Peptide (1-42): Pathological Role & Research Param

  2026-05-11

  Amyloid β-Peptide (1-42) (Aβ42 peptide) drives Alzheimer's pathology via neurotoxicity and ion channel modulation. Quantitative assays demonstrate decreased neuronal viability and specific effects on voltage-gated channels. This dossier details stable, evidence-backed parameters for Aβ42 use in Alzheimer's disease research.

• Kitasamycin for Swine Dysentery: Efficacy and Resistance Ins

  2026-05-11

  This study rigorously evaluates the efficacy of the macrolide antibiotic kitasamycin for controlling swine dysentery (SD) in pigs experimentally infected with Brachyspira hyodysenteriae. By integrating susceptibility profiling, resistance mutation analysis, and controlled challenge trials, the research offers critical insights for antimicrobial stewardship and highlights ongoing challenges in resistance management.

• Cediranib (AZD2171): Applied Workflows for Cancer Research

  2026-05-10

  Cediranib (AZD2171) stands out as a potent, selective angiogenesis inhibitor for in vitro cancer research, enabling precise dissection of VEGFR signaling with robust protocol flexibility. This article delivers actionable, evidence-backed workflows, troubleshooting insights, and strategic comparisons that empower reproducible results and experimental clarity.

• Laminin (925-933): Strategic Insights for Translational ECM

  2026-05-09

  This thought-leadership article provides advanced translational guidance on Laminin (925-933), a synthetic peptide derived from the laminin beta 1 chain, focusing on its mechanistic role in cell adhesion, migration, and chemotaxis. By blending biological rationale, evidence-backed protocol recommendations, and a nuanced competitive landscape review, this piece uniquely connects foundational ECM biology with state-of-the-art translational research strategies. Drawing on recent literature and scenario-driven content assets, the article positions Laminin (925-933) as a benchmark tool for researchers seeking precision and reproducibility in basement membrane and metastasis studies, while critically examining its broader impact in the context of neurodegenerative disease modeling.

• Cyclo (-RGDfC): Precision αvβ3 Integrin Targeting for Cancer

  2026-05-08

  Cyclo (-RGDfC) is a cyclic peptide that selectively targets αvβ3 integrin, enabling robust tumor targeting and integrin-mediated adhesion studies. Its cyclic structure yields high stability and specificity, making it a preferred tool for angiogenesis and cancer research applications. This article details its mechanism, benchmarks, and workflow integration.

• Azathramycin A: Macrolide Antibiotic Workflows for TB Models

  2026-05-08

  Azathramycin A stands out as a precision macrolide antibiotic for modeling Mycobacterium tuberculosis protein synthesis inhibition and antibiotic resistance. This guide details robust experimental workflows, troubleshooting insights, and advanced applications, enabling researchers to maximize reproducibility and interpretative clarity in tuberculosis research.

• Substance P: High-Purity Tachykinin Neuropeptide for CNS Res

  2026-05-07

  Substance P is a tachykinin neuropeptide with verified roles in pain transmission and inflammation. APExBIO’s B6620 offers ≥98% purity and exceptional water solubility, facilitating reproducible pain transmission research. Its precise mechanism via neurokinin-1 receptor binding is foundational for immune response modulation studies.

• SIRT4 Regulation of Glutamine Metabolism Attenuates Liver Fi

  2026-05-07

  This study demonstrates that SIRT4 downregulation in hepatic stellate cells (HSCs) contributes to liver fibrosis by permitting unchecked glutamine metabolism. Restoration of SIRT4 levels or pharmacological inhibition of glutamate dehydrogenase (GDH) reduces HSC proliferation and fibrosis, highlighting a promising metabolic target for chronic liver disease intervention.

• TMEM16F Lipid Scrambling Suppresses Ferroptosis and Boosts I

  2026-05-06

  Yang et al. reveal that TMEM16F-mediated lipid scrambling acts as a late-stage suppressor of ferroptosis by remodeling plasma membrane phospholipids, thereby limiting membrane damage and lytic cell death. The study also demonstrates that inhibiting this process sensitizes tumors to ferroptosis and enhances immune rejection, providing a mechanistic basis for new cancer immunotherapy strategies.

• LDN-193189: Strategic BMP Pathway Modulation in Translation

  2026-05-06

  Explore the mechanistic and translational power of LDN-193189, a highly selective ALK inhibitor, in modulating BMP signaling for stem cell plasticity, epithelial barrier research, and disease modeling. This article bridges evidence from foundational studies and competitive market insights to offer actionable guidance for translational researchers.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L) for Enhanced Im

  2026-05-05

  Leverage the Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody from APExBIO to maximize signal amplification, reproducibility, and sensitivity in Western blot, ELISA, and IHC workflows. Discover protocol optimizations, troubleshooting insights, and practical lessons inspired by cutting-edge apoptosis research.

15267 records 1/1018 page Next 12345 下5页 Last page